id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-305068-9qh8vgtc	Pinto Pereira, João	Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A	2020-09-25		.txt	text/plain	1555	95	41	A 54-year-old man with a long history of severe haemophilia A treated prophylactically with efmoroctocog alpha (3,000 IU twice weekly) was diagnosed with COVID-19 infection. As illustrated by the following observation, this would be more particularly the case for patients with severe haemophilia requiring intensive care and invasive procedures. With a medical history of obesity, diabetes mellitus and hypertension, our patient was particularly illustrative of the population at risk for COVID-19 infection, independently from his history of bleeding disorder [3] . Few data are currently available regarding haemophilic patients requiring invasive procedures following ICU admission for COVID-19 severe infection, with a difficult balance between thromboprophylaxis and prevention of bleeding complications. Our case illustrates that factor VIII concentrates present several desirable features to correct the haemostatic defect in haemophilia A patients with severe COVID-19 infection.	./cache/cord-305068-9qh8vgtc.txt	./txt/cord-305068-9qh8vgtc.txt